Sanofi Benefits From Stockpiling In Q1, Predicts Long-Term Uplift In Supplements Demand

Sanofi benefits from coronavirus-triggered stockpiling in Q1, with Consumer Healthcare head Alan Main suggesting the pandemic may have turned more consumers into regular dietary supplement users

Lyon France, 3 October 2017: White logo of the french multinational pharmaceutical company Sanofi on their glass office building in Lyon France - Image

More from Earnings

More from Business